Scarica l'app Stockscreener
103.72
0.53%
0.55
Dopo l'orario di chiusura:
103.71
-0.01
-0.01%
Vaneck Pharmaceutical Etf Borsa (PPH) Ultime notizie
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Large Volume Increase Following Dividend Announcement - Defense World
Osaic Holdings Inc. Has $1.95 Million Stake in VanEck Pharmaceutical ETF $PPH - Defense World
VanEck ETF TrustVanEck Pharmaceutical ETF announces Quarterly dividend, payable on December 31, 2025 - marketscreener.com
PPH: The Big Pharma ETF (NASDAQ:PPH) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Benzinga
Pharma's $370B Bet on America: The ETF Plays for 2026 - The Globe and Mail
Why PPH Keeps Working When Single Themes Break (NASDAQ:PPH) - Seeking Alpha
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal - sharewise.com
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.6069 - MSN
Fisher Asset Management LLC Sells 1,263,699 Shares of VanEck Pharmaceutical ETF $PPH - Defense World
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation (NYSEARCA:IHE) - Seeking Alpha
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight - Benzinga
Bank of Montreal Can Sells 4,190 Shares of VanEck Pharmaceutical ETF $PPH - Defense World
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs - Benzinga
VanEck Pharmaceutical ETF (Nasdaq:PPH) Stock Quote - FinancialContent
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results - TradingView
Avalon Trust Co Lowers Position in VanEck Pharmaceutical ETF $PPH - Defense World
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' - Benzinga
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs? - TradingView
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.4110 - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
Top Pharmaceutical Companies Shaping The Future Of Healthcare - Seeking Alpha
Top Pharmaceutical Companies Shaping the Future of Healthcare - VanEck
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet - Benzinga
Is VanEck Pharmaceutical (PPH) the Best Healthcare ETF to Buy? - Insider Monkey
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? - sharewise.com
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - The Globe and Mail
Pharmaceutical ETF on track for best week since 2020 - MarketWatch
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Unusually-High Trading Volume Following Dividend Announcement - Defense World
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
0.95%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):